Tanya Curtis Named Executive Consultant for 3RX Holdings Now Expanding in The Pittsburgh Market

Published on July 10, 2016

3RX Pittsburgh, 3RX Holdings’ Pittsburgh location, to offer advanced testing, quality of patient care, compliance and revenue to the Pittsburgh medical community.

Executive Consultant, Tanya Curtis, was selected to expand 3RX Holdings to the Pittsburgh Market.

Richard Harris, national marketing director of 3RX Holdings stated that “3RX is thrilled to have Tanya Curtis spearheading our Pittsburgh expansion. She is a dynamic individual. We know she will be a great addition to the team because as Tanya says : we are saving lives one test at a time.”   

3Rx Holdings is a nationally recognized full service resource for the healthcare community and healthcare professionals. 3RX works hand-in-hand with specialty practices across the country to help improve quality patient care, reduce costs and improve practice profitability through an education and consultation approach. In the best interest of the patient and provider, 3RX shares many specialty offerings, trademarked protocols and algorithms that literally give qualified physicians a distinguished advantage.  

“I am very excited to accept this position to expand 3Rx Holdings to the Pittsburgh market. My reasons for partnering with 3RX are simple. Being a part of revolutionizing the way medication is prescribed to each individual on a personalized basis will save lives one test at a time. Our firm deeply cares about spreading the word in the Pittsburgh market and across the US to increase the quality of patient care and bring awareness that this valuable testing, Pharmacogenomics, is available now,” said Curtis. 

According to the National Library of Medicine, Pharmacogenomics is the study of how genes affect a person’s response to drugs. This relatively new field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications and doses that will be tailored to a person’s genetic makeup.

 “I believe that educating our communities about the dangers of adverse drug reactions and understanding that this testing may one day save a life, a friend’s, family member’s or a child’s is a no brainer.

I personally feel this test should be given to every individual. This way, if they are currently taking medications, they will know which ones are actually working and which drugs are not or which drugs they should never be prescribed.  If a child is injured at school or on the playing field, wouldn’t you want to know if the drug administered to help or save your child will be the right one for them?

If you or your child has to have surgery, wouldn’t you want to know specifically the proper dosage or medication, without a doubt, and that the outcome will be the best it can be and not a surprise reaction or side effect occurring which could have been avoided? 

Allowing a doctor to have the details about you can provide a new pathway for treatment and a better quality of life avoiding negative side effects,” continued Curtis.

Testing, however, is only as good as the methodology behind it. 3RX has a trademark protocol called PAST TM which is one of a kind encompassing methodology. “It is their kryptonite” says Neil Haeger CEO of 3RX Holdings, Inc.

Currently, there is no doubt, anyone taking prescription drugs is at risk at any time of adverse drug reactions.

In an article which was compiled and published by Prof Martin Makary on medical error being the third largest cause of death in the United States and in his interview with Relaxnews (AFP) / MSN.com / May 4, 2016, Prof Makary states that “at least 250,000 people died not from the illnesses or injuries that prompted them to seek hospital care, but from preventable mistakes. That number exceeds deaths from strokes and Alzheimer’s combined and is topped only by heart disease and cancer, which each claim about 600,000 lives per year.

Adverse drug reactions are a significant cause of hospitalizations and deaths in the United States. With the knowledge gained from the Human Genome Project, researchers are learning how inherited differences in genes affect the body’s response to medications. These genetic differences will be used to predict whether a medication will be effective for a particular person and to help prevent adverse drug reactions.”

In “a page from Katie Couric’s Notebook (CBS News) June 28, 2007,” Katie says: “that Pharmacogenomics may be a mouthful, but it is worth paying attention to. It’s the study of how your genes affect your body’s response to drugs. We could save dollars and potentially lives and that’s good medicine.”

Knowing your system and knowing what is in your system before taking a medication can save your life.

3Rx Pittsburgh is seeking independent private practices and practitioners for qualification. Inquiries about pharmacogenomics and eligibility for testing, should be directed to Tanya Curtis, Executive Consultant at 3Rx Pittsburgh  412-855-8359. Further information is also available at this time at http://www.3RXholdings.com

Company Name: Authority Media Communications and Publishing
Contact Person: Carol A Santella
Email: ca.santella@gmail.com
Phone: 4126811105
Country: United States
Website: http://www.yourbusinessmd.com/positioning.html